These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11067651)

  • 21. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years.
    Nichol KL; Goodman M
    Vaccine; 2002 May; 20 Suppl 2():S21-4. PubMed ID: 12110251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccination in healthy working adults in Russia: observational study of effectiveness and return on investment for the employer.
    At'kov OY; Azarov AV; Zhukov DA; Nicoloyannis N; Durand L
    Appl Health Econ Health Policy; 2011 Mar; 9(2):89-99. PubMed ID: 21332253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccine for healthy adult workers: an issue for health authorities or employers?
    Garattini L; Koleva D
    Health Policy; 2011 Sep; 102(1):89-95. PubMed ID: 21093952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficiency of influenza vaccination in the working population in Spain].
    de Juanes JR; Cisterna R; Sanz J; Magaz S; Badia X
    Gac Sanit; 2006; 20(2):101-7. PubMed ID: 16753086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. French economic evaluations of influenza and influenza vaccination.
    Levy E
    Pharmacoeconomics; 1996; 9 Suppl 3():62-6. PubMed ID: 10160489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of vaccination against influenza in healthy, working adults.
    Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of influenza vaccination. Assessment for The Netherlands.
    Postma MJ; Bos JM; van Gennep M; Jager JC; Baltussen R; Sprenger MJ
    Pharmacoeconomics; 1999; 16 Suppl 1():33-40. PubMed ID: 10623374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.
    Pisu M; Meltzer MI; Hurwitz ES; Haber M
    Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
    van Aalst R; Russo EM; Neupane N; Mahmud SM; Mor V; Wilschut J; Chit A; Postma M; Young-Xu Y
    Vaccine; 2019 Jul; 37(32):4499-4503. PubMed ID: 31262590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza cost and cost-effectiveness studies globally--a review.
    Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
    Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral agents for influenza: a comparison of cost-effectiveness data.
    Lynd LD; Goeree R; O'Brien BJ
    Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Raviotta JM; Smith KJ; DePasse J; Brown ST; Shim E; Nowalk MP; Wateska A; France GS; Zimmerman RK
    Vaccine; 2017 Oct; 35(42):5708-5713. PubMed ID: 28890196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons.
    Nichol KL; Nordin J; Mullooly J
    Vaccine; 2006 Mar; 24(10):1562-8. PubMed ID: 16300868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
    Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N
    Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
    Thommes EW; Kruse M; Kohli M; Sharma R; Noorduyn SG
    Hum Vaccin Immunother; 2017 Apr; 13(4):867-876. PubMed ID: 27858509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.
    Quinn E; Jit M; Newall AT
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):425-35. PubMed ID: 24734967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.
    Turner DA; Wailoo AJ; Cooper NJ; Sutton AJ; Abrams KR; Nicholson KG
    Vaccine; 2006 Feb; 24(7):1035-43. PubMed ID: 16183177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices.
    Salleras L; Navas E; Domínguez A; Ibáñez D; Prat A; Garrido P; Asenjo MA; Torner N
    Vaccine; 2009 May; 27(25-26):3454-8. PubMed ID: 19200830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.